“Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth With Ritlecitinib Through Week 48 in Patients With Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b 3 Study”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s293. https://doi.org/10.25251/skin.7.supp.293.